Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis

This study has been terminated.
(low accrual)
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Cephalon
Information provided by (Responsible Party):
Roswell Park Cancer Institute
ClinicalTrials.gov Identifier:
NCT01014546
First received: November 16, 2009
Last updated: July 25, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)